ARCHIVES

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

This article is from The Cancer Letter archive.

Vol. 23 No. 40 | October 17, 1997

Download PDF Visit The Full Archive

Related Articles

Rauscher To Leave ACS when It Moves To Atlanta; Gadberry To Retire In March; Other VPs Stay On

January 8, 1988

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Virus Program Changes reviews Subcommittee Report Set Fro June

November 23, 1974

Senate Subcommittee Approves 3.5 Percent Increase for NIH.

June 29, 2007

Cancer Meetings Listed

March 26, 1993

Phase III Trial: Panobinostat Increases PFS by Four Months

September 26, 2014